DBV Technologies ADR (NASDAQ:DBVT) shares traded 23.14% higher at $0.84 on Wall Street last session.
DBVT stock price is now 8.52% away from the 50-day moving average and -29.32% away from the 200-day moving average. The market capitalization of the company currently stands at $80.57M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
, while ‘Societe Generale’ rates the stock as ‘Buy’
In other news, Mohideen Pharis, Chief Medical Officer sold 1,785 shares of the company’s stock on Jul 29 ’24. The stock was sold for $1,749 at an average price of $0.98. Upon completion of the transaction, the Chief Medical Officer now directly owns 79,367 shares in the company, valued at $66668.28. An SEC document containing details of the transaction can be found on the SEC’s website. On May 24 ’24, Chief Medical Officer Mohideen Pharis sold 660 shares of the business’s stock. A total of $898 was realized by selling the stock at an average price of $1.36. This leaves the insider owning 81,152 shares of the company worth $68167.68. A total of 1.85% of the company’s stock is owned by insiders.
During the past 12 months, DBV Technologies ADR has had a low of $0.50 and a high of $2.28. As of last week, the company has a debt-to-equity ratio of 0.17, a current ratio of 3.29, and a quick ratio of 3.29. The fifty day moving average price for DBVT is $0.7718 and a two-hundred day moving average price translates $1.184945 for the stock.
The latest earnings results from DBV Technologies ADR (NASDAQ: DBVT) was released for 2024-06-30. The company reported revenue of $1.16 million for the quarter, compared to $2.29 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -49.26 percent.